Clinical Trials in Pittsburgh

Showing 14461-14480 of 21,047 trials

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

NCT01613599

This prospective observational study will evaluate the long-term safety of MabThera/Rituxan (rituximab) in participants with granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis. Data will be collected for a maximum of 4 years from participants initiated on MabThera/Rituxan therapy by their physician according to prescribing information.

Granulomatosis With PolyangiitisMicroscopic Polyangiitis

Genentech, Inc.100 participantsStarted Jun 2012

Scottsdale, Arizona, United States • Los Angeles, California, United States • Jacksonville, Florida, United States +12 more locations

UNKNOWN56 miles

TARGET Intracranial Aneurysm Coiling Registry

NCT01748903

The purpose of this prospective registry is to collect real world, post-marketing data on the use of Stryker Target® 360,Target® 2D, and 2nd generation Target® Nano coils for the embolization of ruptured or unruptured intracranial saccular aneurysms. Up to 300 patients (150 in the TARGET 360°/Helical arm and 150 in the New NANO arm) presenting with intracranial aneurysms suitable for coil embolization will be enrolled at up to 20 sites. A post hoc analysis comparing Target® 360° and Target® 2D coil technical and clinical endpoints will be performed.

Intracranial Aneurysms

Mercy Health Ohio150 participantsStarted Feb 2013

Phoenix, Arizona, United States • Tallahassee, Florida, United States • Joliet, Illinois, United States +6 more locations

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

TARGET Intracranial Aneurysm Coiling Registry

Find Trials by Condition in Pittsburgh

Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care

Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma

Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test

Brentuximab Vedotin for Steroid Refractory GvHD

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors

A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines

Intravenous Mepolizumab In Children With Eosinophilic Esophagitis

Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer

Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

Post Approval NovaSure Essure Labeling Study

Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase IV O2 Consumption Study in COPD Patients.

Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women

Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis

Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus

Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease